Quick Answer
Core Scientific, Inc./tx reported Stockholders Equity of -$962.74 million for fiscal year 2025.
Core Scientific, Inc./tx Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | -$962.74M | -2.1% |
| 2024 | -$943.05M | -58.0% |
| 2023 | -$596.94M | -45.8% |
| 2022 | -$409.35M | -130.5% |
| 2021 | $1.34B | +1403.2% |
| 2020 | $89.22M | -16.1% |
| 2019 | $106.33M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$1.13B | -54.6% | -5.9% |
| June 30, 2025 | -$1.06B | +1.8% | -486.6% |
| March 31, 2025 | -$181.51M | +43.0% | +77.9% |
| December 31, 2024 | -$820.18M | -37.4% | -12.4% |
| September 30, 2024 | -$729.39M | -74.2% | +32.7% |
| June 30, 2024 | -$1.08B | -176.2% | -240.3% |
| March 31, 2024 | -$318.51M | +19.9% | +46.6% |
| December 31, 2023 | -$596.94M | -45.8% | -42.6% |
- Core Scientific, Inc./tx showed a decrease of -2.1% in Stockholders Equity compared to the prior fiscal year.
- Over the 2019–2025 period, Core Scientific, Inc./tx’s stockholders equity has declined by 1005.4% (from $106.33 million to -$962.74 million).
- The most recent figure is from Core Scientific, Inc./tx’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 2, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: